Use of short-chain acyl-coa dehydrogenase activators in the preparation of medicaments for the treatment of cancer

By activating short-chain acyl-CoA dehydrogenase using the short-chain acyl-CoA dehydrogenase activator Hypericin, the problem of chemotherapy resistance in colorectal cancer has been solved, achieving a significant inhibitory effect and providing a new drug approach for the treatment of colorectal cancer.

CN122097322APending Publication Date: 2026-05-29金凤实验室
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
金凤实验室
Filing Date
2025-12-24
Publication Date
2026-05-29

Smart Images

  • Figure CN122097322A_ABST
    Figure CN122097322A_ABST
Patent Text Reader

Abstract

The application discloses application of short-chain acyl-CoA dehydrogenase activator in preparation of cancer treatment drugs. The application research finds that the short-chain acyl-CoA dehydrogenase activator has a remarkable effect in treating cancer, thereby first proposing a new use of the short-chain acyl-CoA dehydrogenase activator in preparation of drugs for treating cancer, and providing a new drug and a path for treating cancer, especially for treating colorectal cancer.
Need to check novelty before this filing date? Find Prior Art